LAS VEGAS — Automated direct selective laser trabeculoplasty appears to reduce IOP in patients with primary open-angle glaucoma, according to a speaker here.
“This initial trial demonstrated safety and a signal of efficacy,” Mordechai Goldenfeld, MD, said at the American Society of Cataract and Refractive Surgery meeting.
Goldenfeld and colleagues conducted a prospective, single-arm, nonrandomized, masked clinical trial to evaluate automated direct SLT in 15 patients with primary open-angle glaucoma, ocular hypertension or pseudoexfoliation. The primary outcome measure was the